Pelthos Therapeutics Inc.

PTHSNYSE· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$16.8M

Net Income

-$43.3M

▼ 444.6% YoY

EPS

$-23.04

▼ 61.5% YoY

Cash

$18.0M

▲ 3403.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.